Regenxbio
RGNX
RGNX
181 hedge funds and large institutions have $512M invested in Regenxbio in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 74 increasing their positions, 48 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 30
18% less call options, than puts
Call options by funds: $850K | Put options by funds: $1.04M
43% less capital invested
Capital invested by funds: $896M → $512M (-$385M)
Holders
181
Holding in Top 10
3
Calls
$850K
Puts
$1.04M
Top Buyers
| 1 | +$15.7M | |
| 2 | +$9.16M | |
| 3 | +$5.91M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.69M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
+$2.96M |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$3.88M | |
| 3 | -$3.48M | |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$2.63M |
| 5 |
Morgan Stanley
New York
|
-$2.49M |